111
Participants
Start Date
March 31, 2014
Primary Completion Date
December 15, 2016
Study Completion Date
December 15, 2016
DAS181 dry powder, formulation F02
Lactose Placebo
Weill Cornell Medical College/New York Presbyterian Hospital, New York
Weill Cornell Medical College-Peds, New York
Montefiore Medical Center, The Bronx
University of Rochester Medical Center, Rochester
University of Pittsburgh Medical Center, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Hospital of the University of Pennsylvania, Philadelphia
John Hopkins University School of Medicine, Baltimore
Virginia Commonwealth, Richmond
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
Vanderbilt- Henry-Joyce Cancer Clinic, Nashville
St. Jude Children's Research Hospital, Memphis
Indiana Blood and Marrow Transplantation, Indianapolis
Nationwide Children's, Columbus
Cleveland Clinic, Cleveland
Cincinnati Children's Hospital, Cincinnati
University of Michigan, Ann Arbor
University of Iowa, Iowa City
University of Minnesota, School of Medicine, Minnesota City
Loyola University Medical Center, Maywood
Lurie Children's Hospital, Chicago
University of Chicago, Chicago
Washington University School of Medicine, St Louis
Children's Mercy Hospital, Kansas City
University of Kansas, Kansas City
University of Oklahoma, Oklahoma City
Baylor College of Medicine, Houston
Texas Children's Hospital, Houston
The University of Texas MD Anderson Cancer Center, Houston
Children's Hospital Colorado, Aurora
University of Utah, Salt Lake City
Mayo Clinic-Arizona, Phoenix
City of Hope, Duarte
Ansun Biopharma, Inc, San Diego
Children's Hospital of Orange County, Orange
Stanford University Medical Center, Palo Alto
UC Davis, Sacramento
Seattle Children's Hospital, Seattle
University of Washington Medical Center, Seattle
Beth Israel Deaconess Medical Center, Boston
Brigham & Women's Hospital, Boston
Hackensack University Medical Center, Hackensack
Stonybrook, Stony Brook
Fred Hutchinson Cencer Research Center, Seattle
Lead Sponsor
Ansun Biopharma, Inc.
INDUSTRY